That is essential, because the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error process (tech stocks). Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. This was a breakthrough practically no one saw. But it's going to have profound ramifications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this space, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown 2021 stock predictions). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back maybe significantly before going higher - genetic sequencing companies jeff brown. I've been covering bitcoin for a very long time now. Among the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were primarily educating readers. However that's not the big concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. united states. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are a lot of terrific personal companies on the edge of striking the general public markets And I have actually been working on a brand-new way for you to invest even before these companies go public.
This opportunity has been building over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to book your spot free of charge.
Emma Walsh here, managing editor of the Diary. Regular Journal readers know that tech isn't our normal beat (brownstone research). And when it pertains to tech investing, we leave it to the professionals. Fortunately, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we understand (first lady). In truth, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge picture and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing rapid growth and creating extraordinary chances for financiers. I desire to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. angel investor. But in spite of what numerous readers might think, this is a trend that's simply starting. Although the COVID-19 pandemic disrupted supply chains last year, an excellent 250 million 5G-enabled devices were still sold.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (biotech stocks). Losing two months of manufacturing and sales truly impacts the number of 5G devices are sold in the calendar year. When you think about all of that, selling 250 million units is exceptional. More notably, the hold-ups triggered by the pandemic created a lots of bottled-up need. And that need is now going to be pushed into 2021. In reality, I forecast that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown biotech genome sequencing. And that's not my only 5G forecast When I have actually talked about 5G in the past, I have actually described its three different phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services begin to be provided (tech predictions). That's when we start to see applications operating on 5G networks. Consider things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Phase Three by this summer. This starts something of a virtuous cycle: A lot of individuals don't truly appreciate the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open a suite of extraordinary applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment chances going forward will be enormous. Stepping away from 5G, the next essential innovation I visualize in 2021 is CRISPR genetic editing. CRISPR means "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it is among the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not operate correctly. CRISPR uses a similar concept but with our genetic code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And during that time, there were really only 3 business operating in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're treating diseases and seeing that this technology just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This whole industry is effectively a greenfield chance.
There's room for lots of companies to exist in this area. the legacy report predictions. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or three more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can accurately predict the folding of a protein based solely on its amino acid series with 92. 4% precision. That is very important since the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has actually been a trial-and-error process. However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however numerous drug therapies produced utilizing this technology. This was one of those advancements that practically nobody observed. However it's going to have extensive ramifications for treating disease. And, obviously, there will be plenty of investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back possibly significantly before going greater. I've been covering bitcoin for a long time now. Among the very first research study reports I ever published was on bitcoin - future report review. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. But at the time of that preliminary suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. brownstone research. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the details is up to date since February 2021, but we could not individually verify this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to select winning innovation stocks. He spent more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an exceptional perspective on the marketplace. He's always on the hunt for new chances, and he shares many of his finest picks in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully predicted some of the most significant economic occasions of the past 20 years. Although he does not appear to launch his choices to the general public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it ideal each time, but Jeff Brown's precise forecasts have earned him legions of dedicated fans. That states a lot about his ability. The Near Future Report is released by Brownstone Research study, a prominent monetary research publisher. Brownstone Research uses several research study services with a wide range of expertises - last year.
The business is also affiliated with Bonner & Partners, another well-respected research publisher - jeff brown 2021 stock picks. On its site, Brownstone says its mission is to offer retail financiers with professional-grade research: "For too long, the very best financial investment research has actually not been readily available to specific financiers. It has actually been normally scheduled for investment banks, hedge funds, personal equity, and high-net-worth customers. last year. The mission of Brownstone Research study is to make that sort of exclusive research offered to any investors wanting to get an edge in the markets. The objective is easy to deliver special and lucrative financial investment research study found no place else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also works as the firm's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After years of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you understand even a bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. what is the legacy report predicting. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown believes S.A.V. genetic sequencing companies jeff brown. might be "the greatest pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding two cutting-edge innovations: artificial intelligence and electrical automobiles. Musk hopes the combination will help him establish the very first fully-autonomous, self-driving automobiles ever. It's nothing short of the vehicle market's Holy Grail. As you know, electric vehicles and self-driving cars and truck stocks have actually been huge this year, but the Wall Street device has approved buzz without much tangible outcome. Regardless of an extreme increase in competitors over the past couple of years, Brown still believes Musk has the finest possibility of putting all of it together.
tech could be the magic string that connects all of it together. S.A.V. represents Shared Autonomous Lorry, and it could be the future of transportation. Basically, this technology would enable you to lease your automobile as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the automobile and press a button on an app that tells the cars and truck to "join the fleet." Next thing you know, you're unwinding on your sofa while your automobile shuttles ride-sharers around town. Best of all, you get to keep a large chunk of the revenues. It sounds crazy, however it could be closed than you think.